A new solution for a growing problem: Development of novel treatments for strains of drug-resistant tuberculosis
Julie Glowacki
Abstract
Due to the misuse of antibiotics, drug-resistant strains of tuberculosis (TB) have developed over the last several decades. Current TB medications are often ineffective when it comes to curing patients, therefore new medications are needed to treat these drug-resistant strains of TB. Drugs that target bacterial cell components and interact well with existing TB medications should be considered. Three new medications that should be considered for the use of treating drug-resistant TB are Bedaquiline, PNU-100480, and a topoisomerase inhibitor. By introducing several new medications into the market, drug-resistant TB can be more effectively treated.
